Scientists identify the complex interplay between immune dysfunction, genetics, environment and disease progression driving ...

Growth has surged for road construction firm Construction Partners. Several heavy construction plays are just below buy ...

Travere Therapeutics plummeted Friday after the FDA accepted its review application for a rare kidney disease drug — with one caveat.

A novel targeted drug delivery system could help improve the efficacy of medicines for inflammatory bowel disease (IBD) by ...

AN IRISH athletic therapist has revealed how he lived for years in chronic pain while being dismissed, before finally ...

Absci entered its new drug into Phase I trials in half the time and for many millions of dollars less than it would have cost without AI.

In this interview, Dr Ryan Stidham discusses the various ways in which artificial intelligence is being used to streamline ...

AROUND 50,000 Irish people suffer with inflammatory bowel disease — but due to the nature of the condition, very few are open ...

Most healthy people can get on with their lives and believe in the myth that we are in control of our bodies. Those with IBD ...

Ahead of World IBD Day, Crohn’s and Colitis Ireland have published a new conversation guide to aid better understanding of ...

Three new IL-23 inhibitors have been approved for IBD, threatening Stelara’s long-standing status as the standard of care. Decision making between options relies on physician comfort and ...

The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...